Results 181 to 190 of about 2,301,317 (358)
A Pilot Study on Blood Components in COVID-19 Affected Subjects: A Correlation to UPR Signalling and ER-Stress. [PDF]
Bansal A +6 more
europepmc +1 more source
Blood Components as Carriers for Small‐Molecule Platinum Anticancer Drugs
Houzong Yao, Guangyu Zhu
openalex +2 more sources
Metabolic risk score indexes validation in overweight healthy people
The constellation of adverse cardiovascular disease (CVD) and metabolic risk factors, including elevated abdominal obesity, blood pressure (BP), glucose, and triglycerides (TG) and lowered high-density lipoprotein-cholesterol (HDL-C), has been termed the
Benito Peinado, Pedro José +6 more
core
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Characterization of the interaction of nanobubble ultrasound contrast agents with human blood components. [PDF]
Cooley MB +5 more
europepmc +1 more source
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié +13 more
wiley +1 more source
Interaction of the Blood Components with Ascending Thoracic Aortic Aneurysm Wall: Biomechanical and Fluid Analyses. [PDF]
Taheri RA +5 more
europepmc +1 more source
An Empirical Regression Approach to Estimating Blood Pressure Components [PDF]
Nofiu Idowu Badmus
openalex +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source

